Chen Zhu, CPPCC member and Minister of Health:
The next critical step in healthcare reform, from 2009 to 2011, will focus on five reforms, such as reform of the basic medical insurance system. A planned 850 billion yuan will be put in both the building of the insurance system and the service system.
The insurance system needs to widen coverage and reform of the service system will cover aspects such as medications and public health, especially basic public health.
Regarding the elimination of profiting through raising the prices of medications and medical services in hospitals, Chen said that reform is carried out as a complete solution, and that canceling one regulation will inevitably have a corresponding compensation mechanism. The investment of public finances will play a decisive role in the compensation mechanism.
Ge Junbo, CPPCC member:
China urgently needs to set up a scientific consultation transfer system to shift 95 percent of experts and professors energy toward treating common illnesses and frequently-occurring conditions. At the same time, more investment is needed in medical agencies at the bottom-level.
Zhou Qi, NPC deputy:
Efforts must be made to prevent the reform of public hospitals from backtracking to the old practices of the government undertaking all things, everyone eating from a “big pot” (everyone receiving an equal share regardless of work done), and lack of motivation for doctors.
Public hospitals need to be guided under national policies, human resource management and the distribution system need reformed. A performance assessment mechanism needs to be established, focusing on the assessment of medical institutions and the quality and quantity of medical services provided by doctors, stimulating the motivation of doctors, thus ultimately benefiting patients.
Lu Yanling, NPC deputy:
The commonwealth is the "indicator" for healthcare reform. We must eliminate the practice of "doctors that benefit from selling medicine" and raising prices on medications. We also need to solve issues such as over-priced new medications and the raising of prices at each level of the pharmaceutical retail chain.
By People's Daily Online